Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last days
Enjoy this offer
* See conditions under "Our services"

Valuation: Shivalik Rasayan Limited

Market Cap 349.26Cr 3.69Cr 3.18Cr 2.93Cr 2.75Cr 5.17Cr 5.22Cr 35Cr 13Cr 171.04Cr 14Cr 14Cr 592.73Cr P/E Ratio 2024
69.1x
P/E Ratio 2025 59.1x
Enterprise Value 426.02Cr 4.51Cr 3.88Cr 3.58Cr 3.36Cr 6.3Cr 6.37Cr 42Cr 16Cr 208.62Cr 17Cr 17Cr 722.99Cr EV / Sales 2024
3.49x
EV / Sales 2025 3.4x
Free-Float
40.79%
Yield 2024
0.09%
Yield 2025 0.08%
27/05 Shivalik Rasayan Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026 CI
27/05 Shivalik Rasayan Limited Announces Resignation of Sanjay Bansal as Non-Executive Director, Effective May 27, 2026 CI
27/05 Shivalik Rasayan Limited Recommends Final Dividend for the Financial Year 2025-26 CI
27/05 Shivalik Rasayan Ltd March-quarter consol net profit 45.3 million rupees RE
13/02 Shivalik Rasayan Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025 CI
14/11 Shivalik Rasayan Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2025 CI
29/25/29 Shivalik Rasayan Limited Approves the Re-Designation of Mr. Ashwani Kumar Sharma as a Non-Executive, Non-Independent Director CI
12/25/12 Shivalik Rasayan Limited Reports Earnings Results for the First Quarter Ended June 30, 2025 CI
30/25/30 Shivalik Rasayan Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2025 CI
30/25/30 Shivalik Rasayan Limited announces Annual dividend, payable on October 27, 2025 CI
24/25/24 Medicamen Biotech Limited announced that it has received INR 535.6816 million in funding from Kim Ginnerup ApS, Shivalik Rasayan Limited, VERALOGIX HOLDINGS LTD and other investors CI
26/25/26 Medicamen Biotech Limited announced that it expects to receive INR 775.7875 million in funding from Kim Ginnerup ApS, Shivalik Rasayan Limited, VERALOGIX HOLDINGS LTD CI
04/24/04 Shivalik Rasayan Gets US FDA Nod for Pharmaceutical Ingredient Facility in Gujarat; Shares Rise 3% MT
1 day+3.48%
1 week-3.99%
Current month-22.09%
1 month-11.95%
3 months-12.71%
6 months-39.76%
Current year-36.03%
1 week 214.1
Extreme 214.1
245
1 month 214.1
Extreme 214.1
303
Current year 207.7
Extreme 207.7
371.3
1 year 207.7
Extreme 207.7
652.75
3 years 207.7
Extreme 207.7
890.05
5 years 207.7
Extreme 207.7
1,196.8
10 years 34
Extreme 34
1,196.8
Manager TitleAgeSince
Chief Executive Officer 64 17/11/2018
Director of Finance/CFO - 01/11/2001
Chief Tech/Sci/R&D Officer - 11/01/2024
Director TitleAgeSince
Chairman 61 23/02/2002
Director/Board Member 66 18/07/2003
Director/Board Member - 13/11/2018
Date Insider Type Main position Quantity % Market Cap.
01/24/01Don 21,500 0.1382%
26/24/26Sell 1,08,500 0.6973%
Change 5-day change 1-year change 3-year change Capi.($)
+3.48%-3.99%-58.43%-69.71% 3.67Cr
+1.53%+1.33%+6.13%+33.27% 5.06TCr
+0.11%-.--%-.--%-.--% 1.3TCr
-1.54%-2.05%+99.07%+176.15% 1.22TCr
-1.92%+5.84%+34.12%+78.13% 840.91Cr
-5.91%-3.22%-16.38%-7.84% 742.14Cr
+10.13%+15.17%-1.73%+156.34% 620.35Cr
-0.21%-1.53%-2.70%-9.59% 551.12Cr
+1.70%+7.48%-27.49%-25.27% 454.9Cr
-0.14%+9.65%+3.16%+0.91% 367.54Cr
Average +0.72%+2.53%+3.57%+33.24% 1.12TCr
Weighted average by Cap. +0.62%+1.87%+13.79%+46.85%

Financials

2024 2025
Net sales 271.54Cr 2.87Cr 2.48Cr 2.28Cr 2.14Cr 4.02Cr 4.06Cr 27Cr 10Cr 132.98Cr 11Cr 11Cr 460.83Cr 309.55Cr 3.27Cr 2.82Cr 2.6Cr 2.44Cr 4.58Cr 4.63Cr 31Cr 12Cr 151.59Cr 12Cr 12Cr 525.33Cr
Net income 13Cr 13.45L 11.59L 10.67L 10.02L 18.82L 19.02L 1.26Cr 49.14L 6.23Cr 50.48L 49.41L 22Cr 17Cr 17.66L 15.22L 14.01L 13.16L 24.7L 24.97L 1.66Cr 64.51L 8.18Cr 66.27L 64.87L 28Cr
Net Debt 48Cr 51.01L 43.96L 40.48L 38.01L 71.36L 72.12L 4.78Cr 1.86Cr 24Cr 1.91Cr 1.87Cr 82Cr 77Cr 81.19L 69.97L 64.43L 60.49L 1.14Cr 1.15Cr 7.61Cr 2.97Cr 38Cr 3.05Cr 2.98Cr 130.26Cr
Logo Shivalik Rasayan Limited
Shivalik Rasayan Limited is an India-based company. The Company’s segments are engaged in agrochemicals, active pharma ingredients (API), and pharma formulation. It is the producer of Malathion Technical and Dimethoate Technical. Malathion Technical is a non-systemic, wide spectrum organophosphorus (OP) based contact insecticide. Dimethoate Technical is used in preparation of formulations used in the control of a range of insects and mites. It also manufactures organophosphorus-based insecticides and chemicals. It has a diverse product range and product mix in order to serve consumer requirements. The APIs are being developed and manufactured in the niche area of oncology, ARVs, cardiovascular, metabolic disorders and immunology. It offers solutions from product selection to development to commercialization for a range of oncology and non-oncology products. The Company’s oncology products include Azacitidine, Busulfan, Bortezomib, and various others.
Employees
275
Date Price Change Volume
16/26/16 227.65 +3.48% 3,957
15/26/15 220.00 -2.31% 15,453
12/26/12 225.20 -3.24% 4,021
11/26/11 232.75 -5.00% 286
10/26/10 245.00 +3.22% 1,146
  1. Stock Market
  2. Stocks
  3. SHIVALIK Stock
- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!